Skip to main content
Also available in 4 other languages

العربيةไทยTiếng Việt简体中文

Beginner 5 min read

Xtandi (Enzalutamide): What It Is and What to Expect

Xtandi (Enzalutamide) is a hormone therapy for prostate cancer used to help treat prostate cancer.

NCI source:National Cancer Institute — Enzalutamide

Review status: AI-assisted, editorial review complete. Not reviewed by a clinician. How we check pages

The short answer

Xtandi (Enzalutamide) is a hormone therapy for prostate cancer. It blocks the receptor that lets male hormones (androgens) fuel prostate cancer, which can slow the cancer's growth. It is used to help treat prostate cancer, and is usually given as capsules or tablets taken by mouth each day. Like all cancer medicines it can cause side effects; this page explains the common ones and the warning signs to report. It is educational only and not a substitute for your care team's advice.

  • Xtandi is the brand name; its generic name is enzalutamide.

  • It is a hormone therapy for prostate cancer — it blocks the receptor that lets male hormones (androgens) fuel prostate cancer, which can slow the cancer's growth.

  • It is used to help treat prostate cancer.

  • It is usually given as capsules or tablets taken by mouth each day.

Choose how you want to read this

The whole article, with every detail and caution.

This page is for men who have been prescribed enzalutamide (Xtandi) for prostate cancer, and their families. It covers how the drug works, who it is approved for, key side effects, drug interactions, and when to get help.

Blocking the receptor, not just the hormone

Xtandi is the brand name. Enzalutamide is the generic name. Prostate cancer feeds on androgens, chiefly testosterone. Older hormone treatments lower how much testosterone the body makes. Enzalutamide works one step further along: it blocks the receptor the hormone has to dock with, and it stops that receptor doing its job inside the cell.

The label's usual strength is 160 mg by mouth once a day, with or without food, though your urologist or oncologist may write something different for you — the bottle and the clinic instructions are what to follow. The label says to swallow capsules or tablets whole with plenty of water, and not to chew, crush, split or open them.

Three stages of prostate cancer on the label

  • Castration-resistant prostate cancer, meaning cancer still growing despite testosterone already being low.
  • Metastatic castration-sensitive prostate cancer, where the cancer has spread and still responds to hormone treatment.
  • Non-metastatic castration-sensitive prostate cancer with biochemical recurrence at high risk of spreading. This means a rising PSA after surgery or radiation, with no cancer yet visible on scans.

That third group is the one people most often miss when they read about this drug.

Why most men also stay on hormone injections

For the first two groups, the label says enzalutamide is taken alongside a GnRH analogue injection, or after the testicles have been removed. Blocking the receptor is not enough on its own if testosterone is still being produced. Ask your care team before stopping the injections, even if the tablets seem to be working.

The third group is different. Here enzalutamide can be given with or without a GnRH analogue. The label also allows a planned pause in this one group: after a sustained period with an undetectable PSA, treatment can be suspended and later restarted as PSA changes. The exact thresholds — and whether the pause applies to you at all — are your team's call from your own PSA history. Ask your team before pausing or restarting this drug based on a PSA result.

Seizures, falls and fractures

Seizures occurred in 0.6% of people across eight randomized trials, and they happened anywhere from 13 days to more than 6 years after starting. People at higher risk were generally left out of those trials, so tell your team about any history of seizure, head injury, stroke or brain metastases. A related condition called PRES, which brings headache, confusion, vision loss or seizures, is also listed.

Falls and fractures are a separate and more everyday problem. Bone protection, a look at your other medicines, and simple changes at home are all worth discussing early rather than after a fall.

Also on the label: allergic reactions, heart problems from reduced blood flow, and choking or difficulty swallowing the capsules.

Medicines that can clash

Enzalutamide changes how the liver handles many other drugs, and some drugs change how it is handled in turn. The blood thinner warfarin is one example the label names, and some other medicines can lower enzalutamide levels. It also interferes with certain digoxin blood tests, giving falsely high readings.

Give your pharmacist a full list, including anything bought without a prescription, and ask them before adding anything new.

Living with it day to day

Tiredness is the effect most men report, and it can be considerable. Hot flashes, high blood pressure, and aching joints and back are common too. Blood pressure is checked at visits. PSA and scans track whether it is working; a rising PSA is a reason to talk with your care team, not a reason to stop on your own.

When to get help sooner

  • Call 911 or go to an emergency department if you have a seizure, you become suddenly confused or lose vision, your face or throat swells, you have crushing chest pain, or a fall leaves you unable to stand or bear weight. Do not drive yourself.
  • Call your care team the same day if a capsule sticks or you choke while swallowing it, you fall for no clear reason, or you have bone pain that starts after a knock and does not settle.
  • Call your care team within a day or two if home blood pressure readings keep coming back high, or tiredness and unsteadiness are making you trip around the house.

Sources

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf

https://www.cancer.gov/about-cancer/treatment/drugs/enzalutamide

A man in a bathroom holds a tissue or pill, looking downward

Common questions

What is Xtandi?

Xtandi (Enzalutamide) is a hormone therapy for prostate cancer. It blocks the receptor that lets male hormones (androgens) fuel prostate cancer, which can slow the cancer's growth. It is used to help treat prostate cancer.

How is Xtandi given?

It is usually given as capsules or tablets taken by mouth each day. It is taken as pills or capsules by mouth, often once or twice a day at home. Take it exactly as prescribed and ask your team before stopping or changing it. The exact schedule is set by your care team.

What are the common side effects of Xtandi?

Commonly reported side effects include tiredness, hot flashes, high blood pressure, falls or dizziness, and back or joint aches. Not everyone gets them, and many can be managed. Tell your care team about anything new or worsening.

Does Xtandi cure cancer?

That depends on the person, the cancer type, and its stage. For some people a medicine like this can control cancer for a long time or be part of a curative plan; for others the goal is to slow the cancer or ease symptoms. Your care team can explain the goal in your situation.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Prepared by Cancer Explained's AI-assisted editorial system

Written from National Cancer Institute material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-07-14 what this meansLast updated: 2026-09-29Next planned review: 2027-01-14

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

Knowledge check

0 of 2 answered

  1. Q1.What kind of medicine is Xtandi?
  2. Q2.Which of these is Xtandi used to help treat?

This self-assessment checks understanding of educational content only. It is not medical advice.

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.